The National Agency for Food and Drug Administration and Control (NAFDAC) has placed products marketed by Mofus Nigeria Ltd on its watchlist pending the outcome of an ongoing regulatory investigation. The action follows findings of significant regulatory non-compliance and potential misrepresentation involving products associated with Mofus Nigeria Ltd, Ayrtons Saunders Ltd, UK, and Pharmaserve (North West) Ltd. The case, registered under reference number NAFDAC/PMS/2026/0029, is under active investigation. NAFDAC has commenced a formal investigation, activated continuous surveillance, and issued notifications to stakeholders, while encouraging healthcare professionals and the public to report any quality concerns.
Don't miss out on breaking stories and in-depth articles.
